Guideline Geo (GGEO) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
4 Nov, 2026Executive summary
Q3 sales and order intake declined YoY, while EBITDA and EBIT improved; Jan–Sep EBIT returned to positive territory, supported by cost control and the US restructuring.
Jan–Sep reported revenue fell 1% but rose 6% at comparable currency rates; strategic Asian tenders and infrastructure demand supported activity.
Financial highlights
Q3 net sales were MSEK 42.2 vs 46.0, down 8% YoY or 7% at comparable currency rates; order intake was MSEK 38.7 vs 46.9.
Jan–Sep net sales were MSEK 139.3 vs 140.1; order intake was MSEK 132.4 vs 140.6.
Q3 EBITDA was MSEK 6.1 vs 5.1 and EBIT was MSEK 2.1 vs 0.9; Jan–Sep EBITDA was MSEK 11.6 vs 8.1 and EBIT was MSEK 0.1 vs -5.5.
Q3 net profit was MSEK 1.9 vs 1.5 and EPS was SEK 0.16 vs 0.13; Jan–Sep net profit was MSEK 0.7 vs a loss of 7.0 and EPS was SEK 0.06 vs -0.61.
Q3 operating cash flow was MSEK -3.6 vs 0.9; Jan–Sep operating cash flow was MSEK 9.1 vs 13.1, with net cash of MSEK 16.5 at quarter-end.
Outlook and guidance
Q4 is typically the strongest sales period; management expected a strong Q4, while noting that the outcome remained to be seen.
Pipeline includes more large tenders than a couple of years ago; the Korea and Malaysia wins were cited as evidence of the ability to close larger tenders.
A larger distributor-sales share may lower near-term revenue and profitability per sale, with longer-term potential to expand global reach and scale.
Latest events from Guideline Geo
- Q2 2026 sales up 7%, EMEA surged, EBITDA margin rose to 6.7%, Americas and APAC declined.GGEO
Q2 2026 - Order intake and profitability improved, driven by US growth and major mining contracts.GGEO
Q1 2026 - Net sales up 9% year-over-year, with strong defense orders and resilient profitability.GGEO
Q4 2025 - Q3 saw sharp sales and order growth, with EMEA and APAC leading and US expansion underway.GGEO
Q3 2025 - H1 2025 delivered sales growth and cash flow gains, with Americas and APAC offsetting EMEA weakness.GGEO
Q2 2025 - Q3 sales fell, but strong EBITDA, APAC growth, and new products show resilience.GGEO
Q3 2024 - Q2 sales up 21% with strong order intake, improved margins, and stable liquidity.GGEO
Q2 2024 - Q1 sales up 46% to 49.7 MSEK, with strong cash flow and growth despite currency headwinds.GGEO
Q1 2025 - Record Q4 margins and cash flow driven by APAC growth, product launches, and diversification.GGEO
Q4 2024